BMO Capital Upgrades Ionis Pharmaceuticals (IONS) to Outperform; To Benefit form Alnylam Failure
Go back to BMO Capital Upgrades Ionis Pharmaceuticals (IONS) to Outperform; To Benefit form Alnylam Failure| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 230.25 +5.65 (2.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $224.60 | 52 Week High | $109.10 | |||
| Open | $226.27 | 52 Week Low | $31.38 | |||
| Day High | $230.46 | P/E | N/A | |||
| Day Low | $222.01 | EPS | $-1.45 | |||
| Volume | 680,400 | |||||
| (NASDAQ: IONS) | Delayed: 59.08 +0.45 (0.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.63 | 52 Week High | $62.68 | |||
| Open | $58.41 | 52 Week Low | $19.59 | |||
| Day High | $60.19 | P/E | N/A | |||
| Day Low | $58.02 | EPS | $0.00 | |||
| Volume | 1,218,963 | |||||
